To include your compound in the COVID-19 Resource Center, submit it here.

Topical nitroglycerin: Phase I/II; marketed as Cellogesic in Australia

In a 4-6 week open-label U.S. Phase I/II study in 34 female patients with vulvodynia,

Read the full 154 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE